Northseatiger the reason I speculate on this point is that I see max value with everything thrown into the pot and Cathal has delivered so far .I think personally north of your figure with very little risk and after this timeline who knows !
RE: New Investors to ORPH – Key Reasons to Invest18 Oct 2020 08:52
And don’t forget it was Cathal’s vision to originally “Fix it “ and sell ...but as we all know things have just runaway to the upside utilising mainly the untapped assets within the treasure trove being HVIVO.
RE: New Investors to ORPH – Key Reasons to Invest18 Oct 2020 06:48
I don’t think it’s a question of making them profitable ie Imutex and the sale of a license to Apple or Amazon to Utilise our Genomic database,they already have huge value ... So does Cathal sell these assets before the sale or leave in the company to enhance any sale of Open Orphan ...?
RE: New Investors to ORPH – Key Reasons to Invest18 Oct 2020 03:49
Wallyj,you make an interesting point about ICON taking over ORPH ,I totally agree ,if you remember our very own Proff Brendan Buckley sold his company Firecrest to them and I believe was then ICON’s Chief Scientific Officer until 2017 before partnering Cathal Friel to create Open Orphan .When he joined them ,ICON’s MCP was circa £600 million it is now £11.6 Billion ,they have grown organically but also from strategic acquisitions. Personally I think it is nailed on .